Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report

[1]  A. Fløe,et al.  Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. , 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[2]  S. Buckley,et al.  A case series of rapidly growing mycobacterial catheter-related bloodstream infections among immunocompetent patients , 2020, Journal of clinical tuberculosis and other mycobacterial diseases.

[3]  M. Loebinger,et al.  Nontuberculous Mycobacterial Pulmonary Disease , 2015 .

[4]  A. Ponce-de-León,et al.  Mycobacterium obuense Bacteremia in a Patient with Pneumonia , 2019, Emerging infectious diseases.

[5]  A. Boyd.  Cutaneous infection with Mycobacterium obuense , 2018, International journal of mycobacteriology.

[6]  W. Koh.  Nontuberculous Mycobacteria-Overview. , 2017, Microbiology spectrum.

[7]  A. Dalgleish,et al.  Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer , 2016, British Journal of Cancer.

[8]  C. Chiu,et al.  Draft Genome Sequence of Mycobacterium obuense Strain UC1, Isolated from Patient Sputum , 2015, Genome Announcements.

[9]  C. Daley,et al.  The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  J. Tarrand,et al.  Management of rapidly growing mycobacterial bacteremia in cancer patients. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  I. Raad,et al.  Rapidly growing mycobacterial bloodstream infections. , 2013, The Lancet. Infectious diseases.

[12]  A. Dalgleish,et al.  An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  G. Redelman-Sidi,et al.  Rapidly growing mycobacteria infection in patients with cancer. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Esteban,et al.  Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria , 2008, BMC Microbiology.

[15]  E. Julián,et al.  Surface Spreading Motility Shown by a Group of Phylogenetically Related, Rapidly Growing Pigmented Mycobacteria Suggests that Motility Is a Common Property of Mycobacterial Species but Is Restricted to Smooth Colonies , 2008, Journal of bacteriology.

[16]  N. Ampel.  Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases , 2007 .

[17]  M. A. De Groote,et al.  Infections due to rapidly growing mycobacteria. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  C. Horsburgh,et al.  Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  M. White,et al.  Mycobacterium haemophilum: An emerging pathogen , 1994, European Journal of Clinical Microbiology and Infectious Diseases.

[20]  D. Durack,et al.  Disseminated infection with rapidly growing mycobacteria. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  P M Southern,et al.  Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. , 1992, The Journal of infectious diseases.

[22]  M. Tsukamura,et al.  Numerical Analysis of Rapidly Growing, Scotochromogenic Mycobacteria, Including Mycobacterium obuense sp. nov., nom. rev., Mycobacterium rhodesiae sp. nov., nom. rev., Mycobacterium aichiense sp. nov., nom. rev., Mycobacterium chubuense sp. nov., nom. rev., and Mycobacterium tokaiense sp. nov., nom. , 1981 .

[23]  M. Tsukamura,et al.  Mycobacterium obuense, a rapidly growing scotochromogenic mycobacterium capable of forming a black product from p-aminosalicylate and salicylate. , 1971, Journal of general microbiology.

[24]  E. H. Runyon.  Identification of mycobacterial pathogens utilizing colony characteristics. , 1970, American journal of clinical pathology.

[25]  C. Felix,et al.  The molecular basis of leukemia. , 2004, Hematology. American Society of Hematology. Education Program.

[26]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[27]  T. Davis,et al.  Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  C. Horsburgh.  Epidemiology of disease caused by nontuberculous mycobacteria. , 1996, Seminars in respiratory infections.

[29]  R. Selik,et al.  The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). , 1989, The American review of respiratory disease.

[30]  E. H. Runyon.  Anonymous mycobacteria in pulmonary disease. , 1959, The Medical clinics of North America.